Personalized medicine and cardiovascular disease: from genome to bedside.

Cardiovascular diseases are among the leading causes of morbidity and mortality in the developed world despite advances in cardiac care over the last few decades. Although most of these advances in cardiovascular medicine have been made through trials of therapies on a population scale, the success of such therapies in a patient often is dependent on particular aspects of each individual. In this review, we present the evidence for the impact...

Read More

Website Administration

Outlined are the main elements you will be using to update this website.  Any features not noted in this document can be ignored (they are either not used or are advanced administration settings which should not be modified). WordPress Administration Panel: https://rongchenlab.org/wp-admin   Publications Follow these step to add new publications. Go to the top admin bar and click +New > Post. Add your publication title and add...

Read More

Purification and characterization of trichomaglin-a novel ribosomal-inactivating protein with abortificient activity.

Trichomaglin, a novel ribosome-inactivating protein, has been isolated from root tuber of a plant Maganlin (Trichosanthes Lepiniate, Cucurbitaceae). The isolation and purification procedure included ammonium sulfate precipitation, Sephadex G-75 chromatography and CM-Sephadex C-50 chromatography. The protein was identified to be homogeneous by SDS-PAGE and FPLC analysis. Its molecular weight is 24,673 dalton and isoelectric point is 5.8,...

Read More

Content-based microarray search using differential expression profiles.

BACKGROUND: With the expansion of public repositories such as the Gene Expression Omnibus (GEO), we are rapidly cataloging cellular transcriptional responses to diverse experimental conditions. Methods that query these repositories based on gene expression content, rather than textual annotations, may enable more effective experiment retrieval as well as the discovery of novel associations between drugs, diseases, and other perturbations....

Read More

Matching cancer genomes to established cell lines for personalized oncology.

The diagnosis and treatment of cancers, which rank among the leading causes of mortality in developed nations, presents substantial clinical challenges. The genetic and epigenetic heterogeneity of tumors can lead to differential response to therapy and gross disparities in patient outcomes, even for tumors originating from similar tissues. High-throughput DNA sequencing technologies hold promise to improve the diagnosis and treatment of cancers...

Read More